Nuclear positioning of the BACH2 gene in BCR-ABL positive leukemic cells

Atsushi Ono, Kazuteru Kono, Dai Ikebe, Akihiko Muto, Jiying Sun, Masao Kobayashi, Kazuhiro Ueda, Junia V. Melo, Kazuhiko Igarashi, Satoshi Tashiro

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

BACH2 is a B-cell-specific transcription repressor and is also know as a tumor suppressor in B cell malignancy. Expression of BACH2 is induced in BCR-ABL positive lymphoid cell lines including BV173 by imatinib, a molecular targeting agent for the treatment of chronic myeloid leukemia (CML). Here we show that the activity of the BACH2 gene is related to the nuclear positioning of the gene loci. We examined the spatial association of the BACH2 gene with the centromeric heterochromatin, a transcriptionally repressive subnuclear compartment, by comparing cells with low (BV173 and K562) and high (NAMALWA) levels of BACH2 mRNA. The BACH2 gene was located closer to the centromeric heterochromatin in BV173 and K562 cells as compared to NAMALWA cells. In BV173 cells, the 6ACH2-centromere distance increased after imatinib treatment to levels similar to those in NAMALWA cells. We also found that diethylmaleate, an oxidative stressor, enhanced the antiproliferative effect of imatinib in only BV173 cells. Since BACH2 induces apoptosis by oxidative stress, these observations suggest that down-regulation of the 6ACH2 gene through the interaction with centromeric heterochromatin would take part in leukomogenesis of BCR-ABL positive lymphoid leukemia.

Original languageEnglish
Pages (from-to)67-74
Number of pages8
JournalGenes Chromosomes and Cancer
Volume46
Issue number1
DOIs
Publication statusPublished - 2007 Jan

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Fingerprint

Dive into the research topics of 'Nuclear positioning of the BACH2 gene in BCR-ABL positive leukemic cells'. Together they form a unique fingerprint.

Cite this